Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face.

J Contemp Brachytherapy · 2021 · PMC8060956 · PMID 33897791

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

showed a trendp = 0.06so close (0.05 < p ≤ 0.1)

0%, p = 0.0099; Figure 2B ) and showed a trend towards better 4-year OS (74% vs. 25%, p = 0.06), though had no association with DM.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.